Allianz Asset Management
RYZB

Allianz Asset Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Allianz Asset Management’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,200
Closed -$1.19M – 2289
2023
Q4 		$1.19M Buy
+19,200
New +$477K ﹤0.01% 1535

Allianz Asset Management's RYZB Position: Q1 2024 in Review

Allianz Asset Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 19,200 shares — an estimated $1.19M sold.

Allianz Asset Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $1.19M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Allianz Asset Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allianz Asset Management sold 19,200 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.19M.
  • Allianz Asset Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Allianz Asset Management's RayzeBio, Inc. Common Stock position peaked at $1.19M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Allianz Asset Management's 13F filing for Q1 2024, filed 14 May 2024.